⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RAPP News
Rapport Therapeutics, Inc. Common Stock
Rapala VMC and Okuma Announce New Distribution Agreement in Australia
globenewswire.com
RAPP
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
globenewswire.com
RAPP
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RAPP
Rapala VMC Corporation adds Q1 and Q3 business reviews to its financial reporting in 2026
globenewswire.com
RAPP
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
globenewswire.com
RAPP
Rapport Therapeutics to Present New Phase 2a Data Analysis Further Characterizing RAP-219 in Focal Onset Seizures at 2025 American Epilepsy Society Annual Meeting
globenewswire.com
RAPP
Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update
globenewswire.com
RAPP
Rapport Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
RAPP